A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression

Pao Yen Lin, Shih Yi Huang, Kuan Pin Su

Research output: Contribution to journalArticle

280 Citations (Scopus)

Abstract

Background: On the basis of evidence from studies showing the antidepressant effects of omega-3 polyunsaturated fatty acids and the inverse relation between fish consumption and the prevalence of depression, the phospholipid hypothesis seems promising in ascertaining the etiology and treatment of depression. Although several studies have shown lower levels of omega-3 (n-3) polyunsaturated fatty acids in depressive patients, the results of individual polyunsaturated fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the omega-6 (n-6) polyunsaturated fatty acid arachidonic acid (AA), were inconsistent. Methods: Weconducted the meta-analyses of 14 studies comparing the levels of polyunsaturated fatty acids between depressive patients and control subjects. The effect size of each study was synthesized by using a random effects model. Results: Compared with control subjects, the levels of EPA, DHA, and total n-3 polyunsaturated fatty acids were significantly lower in depressive patients. There was no significant change in AA or total n-6 polyunsaturated fatty acids. Conclusions: The results showed lower levels of EPA, DHA, and total n-3 polyunsaturated fatty acids in patients with depression, thus implying that n-3 polyunsaturated fatty acids play a role in the pathogenesis of depression. Our findings provide further support to the phospholipid hypothesis of depression and a rationale for using n-3 polyunsaturated fatty acids as an alternative treatment for depression. With these results, future studies examining specific roles of DHA and EPA in different clusters of depressive symptoms are warranted.

Original languageEnglish
Pages (from-to)140-147
Number of pages8
JournalBiological Psychiatry
Volume68
Issue number2
DOIs
Publication statusPublished - Jul 15 2010

Fingerprint

Unsaturated Fatty Acids
Omega-3 Fatty Acids
Depression
Eicosapentaenoic Acid
Docosahexaenoic Acids
Arachidonic Acid
Phospholipids
Antidepressive Agents
Meta-Analysis
Fishes
Therapeutics

Keywords

  • Arachidonic acid
  • depression
  • docosahexaenoic acid
  • eicosapentaenoic acid
  • omega-3
  • polyunsaturated fatty acids

ASJC Scopus subject areas

  • Biological Psychiatry
  • Medicine(all)

Cite this

A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. / Lin, Pao Yen; Huang, Shih Yi; Su, Kuan Pin.

In: Biological Psychiatry, Vol. 68, No. 2, 15.07.2010, p. 140-147.

Research output: Contribution to journalArticle

@article{0183e45e980b40b1b0b0ed406d89a1bf,
title = "A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression",
abstract = "Background: On the basis of evidence from studies showing the antidepressant effects of omega-3 polyunsaturated fatty acids and the inverse relation between fish consumption and the prevalence of depression, the phospholipid hypothesis seems promising in ascertaining the etiology and treatment of depression. Although several studies have shown lower levels of omega-3 (n-3) polyunsaturated fatty acids in depressive patients, the results of individual polyunsaturated fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the omega-6 (n-6) polyunsaturated fatty acid arachidonic acid (AA), were inconsistent. Methods: Weconducted the meta-analyses of 14 studies comparing the levels of polyunsaturated fatty acids between depressive patients and control subjects. The effect size of each study was synthesized by using a random effects model. Results: Compared with control subjects, the levels of EPA, DHA, and total n-3 polyunsaturated fatty acids were significantly lower in depressive patients. There was no significant change in AA or total n-6 polyunsaturated fatty acids. Conclusions: The results showed lower levels of EPA, DHA, and total n-3 polyunsaturated fatty acids in patients with depression, thus implying that n-3 polyunsaturated fatty acids play a role in the pathogenesis of depression. Our findings provide further support to the phospholipid hypothesis of depression and a rationale for using n-3 polyunsaturated fatty acids as an alternative treatment for depression. With these results, future studies examining specific roles of DHA and EPA in different clusters of depressive symptoms are warranted.",
keywords = "Arachidonic acid, depression, docosahexaenoic acid, eicosapentaenoic acid, omega-3, polyunsaturated fatty acids",
author = "Lin, {Pao Yen} and Huang, {Shih Yi} and Su, {Kuan Pin}",
year = "2010",
month = "7",
day = "15",
doi = "10.1016/j.biopsych.2010.03.018",
language = "English",
volume = "68",
pages = "140--147",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression

AU - Lin, Pao Yen

AU - Huang, Shih Yi

AU - Su, Kuan Pin

PY - 2010/7/15

Y1 - 2010/7/15

N2 - Background: On the basis of evidence from studies showing the antidepressant effects of omega-3 polyunsaturated fatty acids and the inverse relation between fish consumption and the prevalence of depression, the phospholipid hypothesis seems promising in ascertaining the etiology and treatment of depression. Although several studies have shown lower levels of omega-3 (n-3) polyunsaturated fatty acids in depressive patients, the results of individual polyunsaturated fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the omega-6 (n-6) polyunsaturated fatty acid arachidonic acid (AA), were inconsistent. Methods: Weconducted the meta-analyses of 14 studies comparing the levels of polyunsaturated fatty acids between depressive patients and control subjects. The effect size of each study was synthesized by using a random effects model. Results: Compared with control subjects, the levels of EPA, DHA, and total n-3 polyunsaturated fatty acids were significantly lower in depressive patients. There was no significant change in AA or total n-6 polyunsaturated fatty acids. Conclusions: The results showed lower levels of EPA, DHA, and total n-3 polyunsaturated fatty acids in patients with depression, thus implying that n-3 polyunsaturated fatty acids play a role in the pathogenesis of depression. Our findings provide further support to the phospholipid hypothesis of depression and a rationale for using n-3 polyunsaturated fatty acids as an alternative treatment for depression. With these results, future studies examining specific roles of DHA and EPA in different clusters of depressive symptoms are warranted.

AB - Background: On the basis of evidence from studies showing the antidepressant effects of omega-3 polyunsaturated fatty acids and the inverse relation between fish consumption and the prevalence of depression, the phospholipid hypothesis seems promising in ascertaining the etiology and treatment of depression. Although several studies have shown lower levels of omega-3 (n-3) polyunsaturated fatty acids in depressive patients, the results of individual polyunsaturated fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the omega-6 (n-6) polyunsaturated fatty acid arachidonic acid (AA), were inconsistent. Methods: Weconducted the meta-analyses of 14 studies comparing the levels of polyunsaturated fatty acids between depressive patients and control subjects. The effect size of each study was synthesized by using a random effects model. Results: Compared with control subjects, the levels of EPA, DHA, and total n-3 polyunsaturated fatty acids were significantly lower in depressive patients. There was no significant change in AA or total n-6 polyunsaturated fatty acids. Conclusions: The results showed lower levels of EPA, DHA, and total n-3 polyunsaturated fatty acids in patients with depression, thus implying that n-3 polyunsaturated fatty acids play a role in the pathogenesis of depression. Our findings provide further support to the phospholipid hypothesis of depression and a rationale for using n-3 polyunsaturated fatty acids as an alternative treatment for depression. With these results, future studies examining specific roles of DHA and EPA in different clusters of depressive symptoms are warranted.

KW - Arachidonic acid

KW - depression

KW - docosahexaenoic acid

KW - eicosapentaenoic acid

KW - omega-3

KW - polyunsaturated fatty acids

UR - http://www.scopus.com/inward/record.url?scp=77954204762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954204762&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2010.03.018

DO - 10.1016/j.biopsych.2010.03.018

M3 - Article

C2 - 20452573

AN - SCOPUS:77954204762

VL - 68

SP - 140

EP - 147

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -